Quality improvement is central to achieving high-value care. Learn how we collaborate with all industry stakeholders to identify and bridge measurement gaps and advance patient care.
Need to Know: On June 10, Friends of Cancer Research held a public meeting to discuss how sponsors and FDA may be able to expedite rate-limiting steps in Chemistry, Manufacturing, and Controls (CMC) and current Good Manufacturing Practices (cGMPs) for breakthrough therapy designated products, while ensuring an adequate supply of safe and efficacious product at the time of approval.
Cancer is a burden to patients and the healthcare system. Last year, an estimated 1.6 million new cancer cases were diagnosed in the U.S and the latest figures estimate that 13.4 million people, about 4 percent of the U.S. population, live with cancer in the U.S.1
Achieving a vision of patient-centered healthcare requires multi-stakeholder collaboration each step of the way. As national attention on the use of patient-reported outcomes (PROs) grows, significant progress needs to be made to ensure that they are fairly used for accountability purposes in the context of performance-based payment models.
To help you organize the chaos of the ever-evolving quality measures landscape, we are pleased to introduce the Avalere Quality Measures Navigator (QMN).
Avalere Health led the Pharmacy Quality Alliance's February 2015 Quality Forum Lecture entitled: A Look Ahead at 2015.
As healthcare leaders and policymakers look to curb spending and improve quality, they should examine models like the Alternative Quality Contract (AQC), according to a new paper by Avalere.
Avalere published an article this week on ASCO's plan to launch CancerLinQ™.
Despite its notable negative impact on patient outcomes and costs of care, malnutrition is an area that has largely remained unaddressed by national programs and initiatives.
In 2015, Avalere Health and the Center for Medical Technology Policy will work together to develop the Partnership for Enhanced Recovery to promote broader adoption of proven protocols in the surgical space across a number of US hospitals.
Listen to Avalere's Debbie Lucas explain the complex world of quality measurement.
In the Calendar Year (CY) 2015 End Stage Renal Disease (ESRD) Prospective Payment System (PPS) final rule released on October 31, the Centers for Medicare & Medicaid Services (CMS) finalized a 2015 base per treatment rate of $239.43, up slightly from $239.02 in CY 2014.
"On June 10, 2014, the Center for Medical Technology Policy (CMTP) in collaboration with Avalere Health hosted a multi-stakeholder forum in Baltimore, Maryland, to discuss potential challenges and opportunities to accelerate the adoption of enhanced recovery protocols (ERPs) in the U.S.
Debbie Lucas from Avalere Health will discuss the emerging and complex quality landscape from the perspectives of healthcare stakeholders, including providers, health systems, health plans and others across the industry.
Listen to Debbie Lucas discuss how quality measurement can lead to improvements in the quality of care and the impact on providers.
The use of quality and performance measures in public reporting, value-based purchasing, and alternative payment models is altering clinical practice by providing incentives to improve quality measures performance and provide high-value care. Debbie Lucas helps many stakeholders seek to understand these measures, assess their business impacts, and use the information to guide decision-making.
In the Calendar Year (CY) 2015 End Stage Renal Disease (ESRD) Prospective Payment System (PPS) proposed rule released on July 2, CMS proposes a 2015 base per treatment rate of $239.33, up slightly from $239.02 in CY 2014.
Avalere’s experts will be presenting several posters at AcademyHealth’s Annual Research Meeting in San Diego.
Malnutrition is a leading cause of morbidity and mortality, especially among the elderly.
On Feb. 21, CMS enhanced the Physician Compare website to include the addition of quality measures to indicate the performance achieved on a set number of specific metrics.